KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,326 | -43.1% | 1,510 | -27.1% | 0.01% | -46.7% |
| Q2 2023 | $449,096 | +127484.1% | 2,071 | +6.8% | 0.02% | +36.4% |
| Q1 2023 | $352 | +40.8% | 1,940 | +52.5% | 0.01% | +10.0% |
| Q4 2022 | $250 | -100.0% | 1,272 | -84.2% | 0.01% | -65.5% |
| Q3 2022 | $1,805,000 | +373.8% | 8,027 | +166.8% | 0.03% | +222.2% |
| Q2 2022 | $381,000 | +277.2% | 3,009 | +277.5% | 0.01% | +800.0% |
| Q1 2022 | $101,000 | -74.7% | 797 | -73.9% | 0.00% | -85.7% |
| Q4 2021 | $399,000 | +114.5% | 3,049 | +100.7% | 0.01% | +40.0% |
| Q3 2021 | $186,000 | -42.6% | 1,519 | -46.6% | 0.01% | -37.5% |
| Q2 2021 | $324,000 | +256.0% | 2,842 | +276.9% | 0.01% | +300.0% |
| Q1 2021 | $91,000 | -35.9% | 754 | -46.0% | 0.00% | -50.0% |
| Q4 2020 | $142,000 | +111.9% | 1,397 | +60.6% | 0.00% | +300.0% |
| Q3 2020 | $67,000 | -88.3% | 870 | -83.1% | 0.00% | -95.8% |
| Q2 2020 | $575,000 | – | 5,155 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |